COVID Vaccines
Sort by:
MedCram
COVID-19 Risks of Infection and Early Treatment Recommendations
FEATURING
Roger Seheult
- 88 views
- January 17, 2024
- 1
McMaster University Department of Medicine
Three Years of COVID-19: How Has Our Knowledge and Understanding of COVID-19 Changed?
FEATURING
Dominik Mertz
- 950 views
- January 12, 2024
- 1
McMaster University Department of Medicine
COVID-19 Updates (2024): Seroprevalence, Vaccination, and Therapeutics
FEATURING
Zain Chagla
- 691 views
- January 12, 2024
- 1
Evidence-Based Hair
Top 20 Hair Loss Research Studies 2023: Alopecia Areata (Part 2 of 3)
FEATURING
Jeff Donovan
- 182 views
- January 8, 2024
- 1
Evidence-Based Hair
Top 20 Hair Loss Research Studies 2023 (Part 3 of 3)
FEATURING
Jeff Donovan
- 24 views
- January 8, 2024
MicrobeTV
Outcomes of SARS-CoV-2, Influenza and RSV Infection in Pediatric Communities, Influence of Exposure Length on Transmission of SARS-CoV-2, and Effect of Vaccination on Post-COVID Conditions in Children Between 5-17 Years Old
FEATURING
Daniel Griffin,
Vincent Racaniello
- 6 views
- January 2, 2024
MicrobeTV
The Annual Economic Burden of RSV in Adults in the US, Recombinant or Standard-Dose Influenza Vaccine in Adults Under 65 Years of Age, and Optimal Timing of Nirmatrelvir/Ritonavir Treatment After COVID-19 Symptom Onset or Diagnosis
FEATURING
Daniel Griffin,
Vincent Racaniello
- 78 views
- January 2, 2024
Evidence-Based Hair
COVID-19 and the Risk of Autoimmune Disease, Including Alopecia Areata
FEATURING
Jeff Donovan
- 97 views
- December 6, 2023
Evidence-Based Hair
Alopecia Areata Triggered by COVID-19 Vaccines
FEATURING
Jeff Donovan
- 258 views
- December 6, 2023
- 1
UPMC
Emerging From COVID-19: Lessons Learned and Future Impact
FEATURING
Graham Snyder
- 774 views
- December 6, 2023
- 1
This Week in Virology (TWiV)
Effect of Neutralizing Monoclonal Antibody Treatment on Virologic and Immunologic Biomarkers in Patients With COVID-19, SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy, and Optimization of Antiviral Therapy in Immunocompromised COVID-19 Patients
FEATURING
Daniel Griffin,
Vincent Racaniello
- 92 views
- November 27, 2023
RheumNow
ACR Convergence 2023 Highlights: An Interview with Kevin Winthrop: Three Questions About COVID-19
FEATURING
Kevin Winthrop,
John J. Cush
- 154 views
- November 22, 2023
This Week in Virology (TWiV)
Mpox Neutralizing Antibodies at 6 Months from Mpox Infection or MVA-BN Vaccination, Nirmatrelvir/Ritonavir Use in Pregnant Women with SARS-CoV-2, and Favorable Experience of Transplant Strategy Including Liver Grafts from COVID-19 Donors
FEATURING
Daniel Griffin,
Vincent Racaniello
- 10 views
- November 6, 2023
This Week in Virology (TWiV)
Mpox Neutralizing Antibodies at 6 Months from Mpox Infection or MVA-BN Vaccination, Nirmatrelvir and Molnupiravir and Post-COVID-19 Condition in Older Patients, and Association Between Guillain-Barré Syndrome and COVID-19 Infection and Vaccination
FEATURING
Daniel Griffin,
Vincent Racaniello
- 8 views
- November 1, 2023
This Week in Virology (TWiV)
High Influenza Incidence and Disease Severity Among Children and Adolescents Aged <18 Years, Serotonin Reduction in Post-Acute Sequelae of Viral Infection, and Antiviral Efficacy of Molnupiravir Vs Ritonavir-Boosted Nirmatrelvir in Patients With Early Symptomatic COVID-19
FEATURING
Daniel Griffin,
Vincent Racaniello
- 12 views
- October 25, 2023